Literature DB >> 27113267

Long-term activation of the innate immune system in atherosclerosis.

Anette Christ1, Siroon Bekkering2, Eicke Latz3, Niels P Riksen4.   

Abstract

Efforts to reverse the pathologic consequences of vulnerable plaques are often stymied by the complex treatment resistant pro-inflammatory environment within the plaque. This suggests that pro-atherogenic stimuli, such as LDL cholesterol and high fat diets may impart longer lived signals on (innate) immune cells that persist even after reversing the pro-atherogenic stimuli. Recently, a series of studies challenged the traditional immunological paradigm that innate immune cells cannot display memory characteristics. Epigenetic reprogramming in these myeloid cell subsets, after exposure to certain stimuli, has been shown to alter the expression of genes upon re-exposure. This phenomenon has been termed trained innate immunity or innate immune memory. The changed responses of 'trained' innate immune cells can confer nonspecific protection against secondary infections, suggesting that innate immune memory has likely evolved as an ancient mechanism to protect against pathogens. However, dysregulated processes of immunological imprinting mediated by trained innate immunity may also be detrimental under certain conditions as the resulting exaggerated immune responses could contribute to autoimmune and inflammatory diseases, such as atherosclerosis. Pro-atherogenic stimuli most likely cause epigenetic modifications that persist for prolonged time periods even after the initial stimulus has been removed. In this review we discuss the concept of trained innate immunity in the context of a hyperlipidemic environment and atherosclerosis. According to this idea the epigenome of myeloid (progenitor) cells is presumably modified for prolonged periods of time, which, in turn, could evoke a condition of continuous immune cell over-activation.
Copyright © 2016 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Changed dietary components; Epigenetic reprogramming; Hyperlipidemia; Immuno-metabolism; Innate immune memory; Trained innate immunity

Mesh:

Year:  2016        PMID: 27113267     DOI: 10.1016/j.smim.2016.04.004

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  35 in total

1.  [Oxidized low-density lipoprotein modulates differentiation of murine memory CD8+ T cell subpopulations].

Authors:  Hua Zheng; Ze-Hang Lin; Yan-Mei Zhang; Chen-Fei Zhou; Xuan Liu; Sha Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-08-20

Review 2.  JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.

Authors:  Daniella M Schwartz; Yuka Kanno; Alejandro Villarino; Michael Ward; Massimo Gadina; John J O'Shea
Journal:  Nat Rev Drug Discov       Date:  2017-11-06       Impact factor: 84.694

3.  JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.

Authors:  Daniella M Schwartz; Yuka Kanno; Alejandro Villarino; Michael Ward; Massimo Gadina; John J O'Shea
Journal:  Nat Rev Drug Discov       Date:  2017-12-28       Impact factor: 84.694

Review 4.  Epigenetic Regulation of Vascular Diseases.

Authors:  Abdalrahman Zarzour; Ha Won Kim; Neal L Weintraub
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-06       Impact factor: 8.311

Review 5.  The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis.

Authors:  Angela Pirillo; Fabrizia Bonacina; Giuseppe Danilo Norata; Alberico Luigi Catapano
Journal:  Curr Atheroscler Rep       Date:  2018-02-14       Impact factor: 5.113

Review 6.  Trained Immunity as a Trigger for Atherosclerotic Cardiovascular Disease-A Literature Review.

Authors:  Natalia Anna Zieleniewska; Małgorzata Kazberuk; Małgorzata Chlabicz; Andrzej Eljaszewicz; Karol Kamiński
Journal:  J Clin Med       Date:  2022-06-12       Impact factor: 4.964

7.  Evaluation of the Cytotoxic, Anti-Inflammatory, and Immunomodulatory Effects of Withaferin A (WA) against Lipopolysaccharide (LPS)-Induced Inflammation in Immune Cells Derived from BALB/c Mice.

Authors:  Abdullah M Alnuqaydan; Abdulmajeed Almutary; Gh Rasool Bhat; Tanveer Ahmad Mir; Shadil Ibrahim Wani; Mohd Younis Rather; Shabir Ahmad Mir; Bader Alshehri; Sulaiman Alnasser; Faten M Ali Zainy; Bilal Rah
Journal:  Pharmaceutics       Date:  2022-06-13       Impact factor: 6.525

8.  BCG vaccination in humans inhibits systemic inflammation in a sex-dependent manner.

Authors:  Valerie Acm Koeken; L Charlotte J de Bree; Vera P Mourits; Simone Jcfm Moorlag; Jona Walk; Branko Cirovic; Rob Jw Arts; Martin Jaeger; Helga Dijkstra; Heidi Lemmers; Leo Ab Joosten; Christine S Benn; Reinout van Crevel; Mihai G Netea
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

9.  In Vitro Experimental Model of Trained Innate Immunity in Human Primary Monocytes.

Authors:  Siroon Bekkering; Bastiaan A Blok; Leo A B Joosten; Niels P Riksen; Reinout van Crevel; Mihai G Netea
Journal:  Clin Vaccine Immunol       Date:  2016-12-05

Review 10.  Epigenetics and Trained Immunity.

Authors:  Charlotte D C C van der Heijden; Marlies P Noz; Leo A B Joosten; Mihai G Netea; Niels P Riksen; Samuel T Keating
Journal:  Antioxid Redox Signal       Date:  2017-11-21       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.